WASHINGTON--(BUSINESS WIRE)--The Halifax Group (“Halifax”) and SV Life Sciences today announced the completion of a management-led recapitalization of Trio Clinical Research (“Trio”), a unique clinical research services company which provides a full suite of clinical trial services to the biopharmaceutical industry. Trio bridges the gap between full-service clinical research organizations (CROs) and traditional staffing companies by providing trial management, functional outsourcing, and professional resourcing services.
